BP002388-PRO-742: Recombinant Human Cellular tumor antigen p53 (p53) Protein
Source: E. coli-derived.BP002398-PRO-606: Recombinant Human Programmed Cell Death Protein 4 (PDCD4)
Source: E. coli-derived.
Purity: > 90.0% by RP-HPLC and SDS-PAGE.BP002399-PRO-624: Recombinant Human Programmed Cell Death 5 (PDCD5) Protein
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP002400-PRO-184: Recombinant Human Programmed Cell Death 6 (PDCD6) Protein
Source: E. coli-derived.
Purity: > Greater than 95% as determined by SDS-PAGE.BP002401-PRO-792: Recombinant Human Programmed Cell Death 6 Interacting Protein (PDCD6IP)
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP002094-PRO-200: Recombinant Human Vesicular overexpressed in cancer prosurvival protein 1 (VOPP1) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP002433-PRO-1077: Recombinant Human HAUS Augmin-Like Complex Subunit 1 (HAUS1) Protein
Source: E. coli-derived.
Purity: > 85.0% by SDS-PAGE.BP000153-CYT-096: Recombinant Human Interleukin-3 (IL3) Protein, HEK
Source: HEK-derived.
The activity was determined by the dose dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-2 ug/ml.
Purity: > 90% as obsereved by SDS-PAGE.BP000153-CYT-156: Recombinant Rhesus Macaque Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 97.0% by SDS-PAGE.BP000153-CYT-210: Recombinant Human Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.